| Page Range | 27473-27473 | |
| FR Document | 2016-10731 |
[Federal Register Volume 81, Number 88 (Friday, May 6, 2016)] [Notices] [Page 27473] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-10731] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Noramco, Inc. ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Noramco, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated November 23, 2015, and published in the Federal Register on December 3, 2015, 80 FR 75692, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Codeine-N-oxide (9053)..................... I Dihydromorphine (9145)..................... I Morphine-N-oxide (9307).................... I Amphetamine (1100)......................... II Methylphenidate (1724)..................... II Phenylacetone (8501)....................... II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Hydrocodone (9193)......................... II Morphine (9300)............................ II Oripavine (9330)........................... II Thebaine (9333)............................ II Opium extracts (9610)...................... II Opium fluid extract (9620)................. II Opium tincture (9630)...................... II Opium, powdered (9639)..................... II Opium, granulated (9640)................... II Oxymorphone (9652)......................... II Noroxymorphone (9668)...................... II Tapentadol (9780).......................... II ------------------------------------------------------------------------ The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Dated: April 29, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-10731 Filed 5-5-16; 8:45 am] BILLING CODE 4410-09-P
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 81 FR 27473 |